Fractional Flow Guided Coronary Artery Bypass Grafting: A Word of Caution Running title: Lazar; Fractional flow and coronary surgery

Fractional flow-guided coronary artery bypass grafting: a word of caution.

Competitive flow and arterial graft a word of caution.

reliable, exclusively in appropriately selected situations. In creation of bypass grafts, durable completeness of revascularization and function of the ITA to the LAD bypass should not be compromised. We would suggest that the balanced bypass flow toward the LAD and the RCA is noticeably important to achieve an entire patency of the Y-graft for three-vessel regions. This study is not conclusive...

Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery.

BACKGROUND Fractional flow reserve (FFR) is well established for patients undergoing percutaneous coronary intervention, yet little is known about candidates for coronary artery bypass graft surgery. METHODS AND RESULTS From 2006 to 2010, we retrospectively included in this registry 627 consecutive patients treated by coronary artery bypass graft surgery having at least 1 angiographically int...

Coronary-Artery Bypass Grafting.

To the Editor: In their article on coronary-artery bypass grafting (CABG), Alexander and Smith (May 19 issue)1 state that “the usefulness of FFR [fractional flow reserve] in selecting patients with multivessel coronary artery disease for CABG or in identifying bypass graft targets in patients undergoing CABG has not been studied.” However, a prospective study by Botman et al.2 showed a relation...

Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial

AIM We assessed the management and outcomes of non-ST segment elevation myocardial infarction (NSTEMI) patients randomly assigned to fractional flow reserve (FFR)-guided management or angiography-guided standard care. METHODS AND RESULTS We conducted a prospective, multicentre, parallel group, 1 : 1 randomized, controlled trial in 350 NSTEMI patients with ≥1 coronary stenosis ≥30% of the lume...